Main Article Content
Background: Surgical site infections (SSIs) are one of the most frequent complications associated with surgeries and contribute significantly to morbidity and mortality if not treated promptly. Poor prognosis associated with SSIs could be partly attributed to the increase in antimicrobial resistance among the causative agents.
Case Presentation: This is a case of SSI due to multi-drug resistant (MDR) E. coli associated with intestinal perforation surgery treated successfully with CSE-1034.
Conclusions: CSE-1034 can be effectively used for the treatment of MDR SSIs. Utilizing CSE-1034 as an empiric therapy for SSIs could save time, the spread of resistance and can help to cut hospital-associated costs.